MedTrace Logo

Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use Disorders

NCT00447733 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2012-03-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether Integrated Treatment is effective in the treatment of anxiety and/or depression with co-occurring substance use disorders.

Conditions

Interventions

BEHAVIORAL

Integrated mental health and substance use treatment

Psychosocial and drug treatment targeting both the substance use disorder and the psychiatric disorder in an integrated and comprehensive way.

BEHAVIORAL

Treatment as usual

Non-standardized psychiatric outpatient treatment

Sponsors & Collaborators

  • SINTEF Health Research

    collaborator OTHER

  • University of Oslo

    lead OTHER

Principal Investigators

  • Rolf W. Gråwe, Ph.D · Alcohol and Drug Treatment Health Trust in Central Norway; Norwegian Centre of Addiction Research, University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2010-12-31
Completion
2010-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00447733 on ClinicalTrials.gov